Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Armstrong

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 3, 2012
Cardiac arrest and possible seizure activity after vincristine injectionAngela S Lennon, Grace Norales, Michael B Armstrong
Pediatric Neurology|October 26, 2005
Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresisMichael B Armstrong, Patricia L Robertson, Valerie P Castle
Translational Oncology|March 10, 2015
Mxi1 and mxi1-0 antagonize N-myc function and independently mediate apoptosis in neuroblastomaDavid A Erichsen, Michael B Armstrong, Daniel S Wechsler
The Journal of Applied Psychology|October 21, 2021
Theory-driven game-based assessment of general cognitive ability: Design theory, measurement, prediction of performance, and test fairnessRichard N Landers, Michael B Armstrong, Andrew B Collmus, et al.
American Journal of Medical Genetics. Part A|February 13, 2013
Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locusDavid Van Mater, Erik H Knelson, Kathleen A Kaiser-Rogers, et al.
Journal of Pediatric Hematology/Oncology|July 14, 2005
Testicular chloroma in a nonleukemic infantMichael B Armstrong, Olubukola O Nafiu, Riccardo Valdez, et al.
Journal of Experimental Therapeutics & Oncology|September 6, 2008
Bortezomib as a therapeutic candidate for neuroblastomaMichael B Armstrong, Kurt R Schumacher, Rajen Mody, et al.
The Journal of Clinical Investigation|November 13, 2013
Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastomaErik H Knelson, Angela L Gaviglio, Alok K Tewari, et al.
Neoplasia (New York, N.Y.)|January 10, 2014
N-Myc differentially regulates expression of MXI1 isoforms in neuroblastomaMichael B Armstrong, Rajen J Mody, D Christian Ellis, et al.
JIMD Reports|February 23, 2013
Hereditary intrinsic factor deficiency in chaldeansAmy C Sturm, Elizabeth C Baack, Michael B Armstrong, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 3, 2012
Cardiac arrest and possible seizure activity after vincristine injectionAngela S Lennon, Grace Norales, Michael B Armstrong
Pediatric Neurology|October 26, 2005
Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresisMichael B Armstrong, Patricia L Robertson, Valerie P Castle
Translational Oncology|March 10, 2015
Mxi1 and mxi1-0 antagonize N-myc function and independently mediate apoptosis in neuroblastomaDavid A Erichsen, Michael B Armstrong, Daniel S Wechsler
The Journal of Applied Psychology|October 21, 2021
Theory-driven game-based assessment of general cognitive ability: Design theory, measurement, prediction of performance, and test fairnessRichard N Landers, Michael B Armstrong, Andrew B Collmus, et al.
American Journal of Medical Genetics. Part A|February 13, 2013
Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locusDavid Van Mater, Erik H Knelson, Kathleen A Kaiser-Rogers, et al.
Journal of Pediatric Hematology/Oncology|July 14, 2005
Testicular chloroma in a nonleukemic infantMichael B Armstrong, Olubukola O Nafiu, Riccardo Valdez, et al.
Journal of Experimental Therapeutics & Oncology|September 6, 2008
Bortezomib as a therapeutic candidate for neuroblastomaMichael B Armstrong, Kurt R Schumacher, Rajen Mody, et al.
The Journal of Clinical Investigation|November 13, 2013
Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastomaErik H Knelson, Angela L Gaviglio, Alok K Tewari, et al.
Neoplasia (New York, N.Y.)|January 10, 2014
N-Myc differentially regulates expression of MXI1 isoforms in neuroblastomaMichael B Armstrong, Rajen J Mody, D Christian Ellis, et al.
JIMD Reports|February 23, 2013
Hereditary intrinsic factor deficiency in chaldeansAmy C Sturm, Elizabeth C Baack, Michael B Armstrong, et al.
Pageof 2